Dutch court finds olanzapine patent invalid
The Dutch first instance patent court has held Eli Lilly`s olanzapine patent invalid for lack of novelty. The patent has been found to be valid in several other jurisdictions, including Germany and England.
Please login or register with elexica to view our content
elexica is our free online legal resource - you don't have to be a client of Simmons & Simmons to access content.
Not registered? Register on elexica here.